Medication Persistence Rates and Factors Associated with Persistence in Patients Following Stroke: A Cohort Study
Open Access
- 10 July 2008
- journal article
- Published by Springer Nature in BMC Neurology
- Vol. 8 (1) , 25
- https://doi.org/10.1186/1471-2377-8-25
Abstract
Medication nonadherence can be as high as 50% and results in suboptimal patient outcomes. Stroke patients in particular can benefit from pharmacotherapy for thrombosis, hypertension, and dyslipidemia but are at high risk for medication nonpersistence.Keywords
This publication has 38 references indexed in Scilit:
- Discontinuation of Statin Therapy and Clinical Outcome After Ischemic StrokeStroke, 2007
- In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-upStroke, 2004
- Medication Non-Adherence in the ElderlyDrugs & Aging, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Compliance With Secondary Prevention of Ischemic StrokeStroke, 2001
- Preventing Ischemic Stroke in Patients With Prior Stroke and Transient Ischemic AttackStroke, 1999
- How Do Stroke Units Improve Patient Outcomes?Stroke, 1997
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1989
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982